Men with locally advanced prostate cancer have a better survival chance if they receive radiotherapy along with androgen deprivation therapy (ADT). This data was presented at the recent American Society of Clinical Oncology (ASCO) 2012 conference. Professor Malcom Mason from Whales University discussed a trial he conducted that demonstrated that for a man diagnosed with locally advanced prostate cancer their survival advantage is more than doubled by adding radiation to ADT. He also commented that in most instances radiotherapy does not have long term toxicities.
Dr. Malcom said that the results of his study means that any man diagnosed with locally advanced prostate cancer should discuss with their oncologist combining radiotherapy along with ADT.
An interesting interview with Dr. Malcom is available on You Tube at www.youtube.com/watch?v=DWnDMXlSEGc
Joel T Nowak, M.A., M.S.W.